Heat Biologics Inc.

AMEX: HTBX · Real-Time Price · USD
2.38
0.01 (0.42%)
At close: May 03, 2022, 6:00 AM

Heat Biologics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
212.42K -347.96K 501.57K 459.49K 538.64K
Cost of Revenue
n/a n/a n/a n/a n/a
Gross Profit
212.42K -347.96K 501.57K 459.49K 538.64K
Operating Income
-8M -13.5M -7.57M -6.72M -7.64M
Interest Income
120.7K 248.01K 195.34K 176.8K 195.16K
Pretax Income
-8.19M -13.75M -7.55M -6.62M -7.62M
Net Income
-8.31M -13.61M -7.43M -6.54M -7.53M
Selling & General & Admin
3.78M 5.82M 3.39M 2.85M 4.77M
Research & Development
3.93M 6.82M 4.38M 4.22M 3.41M
Other Expenses
n/a 1.88M n/a n/a n/a
Operating Expenses
7.71M 14.52M 7.77M 7.07M 8.17M
Interest Expense
120.7K 541.03K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a
Cost & Expenses
7.71M 14.52M 7.77M 7.07M 8.17M
Income Tax Expense
120.7K -145.97K 16.84K 94.49K 18.11K
Shares Outstanding (Basic)
25.59M 25.14M 25.14M 25.14M 24.2M
Shares Outstanding (Diluted)
25.59M 25.14M 25.14M 25.14M 24.2M
EPS (Basic)
-0.32 -0.54 -0.3 -0.26 -0.31
EPS (Diluted)
-0.32 -0.54 -0.3 -0.26 -0.31
EBITDA
-7.79M -14.04M -7.25M -6.41M -7.43M
EBIT
-8.07M -13.21M n/a n/a n/a
Depreciation & Amortization
207.11K -541.03K 178.11K 135.36K 101.8K